The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE | COM | 00032Q104 | 44,919 | 1,529,402 | SH | SOLE | 44,919 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,535 | 140,839 | SH | SOLE | 2,535 | 0 | 0 | ||
ALLAKOS | COM | 01671P100 | 1,853 | 17,500 | SH | SOLE | 1,853 | 0 | 0 | ||
ALTIMMUNE | COM NEW | 02155H200 | 1,697 | 150,000 | SH | SOLE | 1,697 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 2,488 | 75,500 | SH | SOLE | 2,488 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 7,585 | 121,500 | SH | SOLE | 7,585 | 0 | 0 | ||
ASTRIA THERAPEUTICS | COM | 06435X102 | 1,387 | 156,927 | SH | SOLE | 1,387 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 2,789 | 297,362 | SH | SOLE | 2,789 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 2,450 | 250,000 | SH | Call | SOLE | 438 | 0 | 0 | |
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 1,478 | 60,000 | SH | SOLE | 1,478 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 8,397 | 843,122 | SH | SOLE | 8,397 | 0 | 0 | ||
BELLUS HEALTH | COM NEW | 07987C204 | 12,326 | 2,007,500 | SH | SOLE | 12,326 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC SPONSORED ADS | SPONSORED ADS | 088786108 | 1,588 | 38,184 | SH | SOLE | 1,588 | 0 | 0 | ||
C4 THERAPEUTICS STK | COM STK | 12529R107 | 938 | 21,000 | SH | SOLE | 938 | 0 | 0 | ||
CABALETTA BIO | COM | 12674W109 | 3,684 | 302,926 | SH | SOLE | 3,684 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 1,500 | 365,000 | SH | SOLE | 1,500 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 18,222 | 337,500 | SH | SOLE | 18,222 | 0 | 0 | ||
CHIMERIX | COM | 16934W106 | 1,300 | 210,000 | SH | SOLE | 1,300 | 0 | 0 | ||
CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 7,898 | 1,316,268 | SH | SOLE | 7,898 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,102 | 301,904 | SH | SOLE | 1,102 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 6,879 | 391,974 | SH | SOLE | 1,271 | 0 | 0 | ||
ELANCO ANIMAL HEALTH | COM | 28414H103 | 925 | 29,000 | SH | SOLE | 925 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,854 | 369,863 | SH | SOLE | 3,854 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 9,098 | 322,500 | SH | SOLE | 9,098 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 8,675 | 393,250 | SH | SOLE | 3,309 | 0 | 0 | ||
GOSSAMER BIO | COM | 38341P102 | 2,703 | 215,000 | SH | SOLE | 2,703 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,882 | 392,500 | SH | SOLE | 3,882 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 9,235 | 374,495 | SH | SOLE | 9,235 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 18,432 | 1,135,000 | SH | SOLE | 18,432 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 5,484 | 562,500 | SH | SOLE | 5,484 | 0 | 0 | ||
KRYSTAL BIOTECH | COM | 501147102 | 3,788 | 72,551 | SH | SOLE | 3,788 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 5,467 | 291,884 | SH | SOLE | 5,467 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 2,684 | 122,000 | SH | SOLE | 2,684 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 480 | 2,315 | SH | SOLE | 480 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 242 | 90,832 | SH | SOLE | 242 | 0 | 0 | ||
OLEMA PHARMACEUTICALS | COM | 68062P106 | 4,148 | 150,500 | SH | SOLE | 4,148 | 0 | 0 | ||
RAIN THERAPEUTICS INC | COM | 75082Q105 | 2,730 | 182,500 | SH | SOLE | 2,730 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 1,761 | 17,500 | SH | SOLE | 1,761 | 0 | 0 | ||
SEELOS THERAPEUTICS INC | COM | 81577F109 | 6,893 | 2,860,000 | SH | SOLE | 6,893 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 4,263 | 1,024,668 | SH | SOLE | 4,263 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,939 | 206,126 | SH | SOLE | 3,939 | 0 | 0 | ||
UNITED THERAPEUTICS DEL | COM | 91307C102 | 554 | 3,000 | SH | SOLE | 554 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 6,217 | 2,018,433 | SH | SOLE | 6,217 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 4,204 | 260,000 | SH | SOLE | 4,204 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS | COM | 92790C104 | 2,234 | 135,807 | SH | SOLE | 2,234 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 32,135 | 11,728,033 | SH | SOLE | 32,135 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,378 | 417,409 | SH | SOLE | 6,378 | 0 | 0 |